First Rounders: Harvey Berger
Release Date:
Nature Biotechnology spoke to Harvey Berger about developing Iclusig, the difference between managing a patient's health and running a company, and how a public entity deals with bad news. Hosted on Acast. See acast.com/privacy for more information.
First Rounders: Harvey Berger